Advertisement
Screener

ImageneBio, Inc. (IMA) Patents: Active

ImageneBio, Inc. Active Patents

16 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-11-13: Application 18507616; Invention MEK INHIBITORS AND USES THEREOF; Applicant Ikena Oncology, Inc.; Status Patented Case.
  • 2023-05-25: Application 18323700; Invention MEK INHIBITORS AND USES THEREOF; Applicant Ikena Oncology, Inc.; Status Patented Case.
  • 2023-02-09: Application 18166689; Invention ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF; Applicant Ikena Oncology, Inc.; Status Patented Case.
  • 2023-01-19: Application 18156562; Invention SOLID FORMS OF (R)-N-(2-(5-FLUOROPYRIDIN-3-YL)-8-ISOPROPYLPYRAZOLO[1,5-a][1,3,5]TRIAZIN-4-YL)-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-3-AMINE AS ARYL HYDROCARBON RECEPTOR (AHR) INHIBITORS; Applicant Ikena Oncology, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-11-1318507616MEK INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2025-11-0412459895US20240190822A1
Alfredo C. CASTRO
Michael J. Burke
Thomas A. Wynn
Sabine K. Ruppel
Sergio L. Santillana Soto
Eric Haines
Lan Xu
Oksana Zavidij
United States
United States
United States
United States
United States
United States
United States
United States
LEESER, ERICH A
2023-05-2518323700MEK INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2024-01-2311878958US20230382863A1
Alfredo C. CASTRO
Michael J. BURKE
Thomas A. WYNN
Sabine K. RUPPEL
Sergio L. SANTILLANA SOTO
Eric HAINES
Lan XU
Oksana ZAVIDIJ
United States
United States
United States
United States
United States
United States
United States
United States
LEESER, ERICH A
2023-02-0918166689ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOFIkena Oncology, Inc.Patented Case2024-07-0912030876US20230295147A1
Alfredo C. CASTRO
Karen J. McGovern
Michael Burke
United States
United States
United States
STOCKTON, LAURA LYNNE
2023-01-1918156562SOLID FORMS OF (R)-N-(2-(5-FLUOROPYRIDIN-3-YL)-8-ISOPROPYLPYRAZOLO[1,5-a][1,3,5]TRIAZIN-4-YL)-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-3-AMINE AS ARYL HYDROCARBON RECEPTOR (AHR) INHIBITORSIkena Oncology, Inc.Patented Case2024-12-1012162884US20230286990A1
Alfredo C. Castro
James Martin Nolan III
Sarah Jean Bethune
Corinne Marie Folberth
United States
United States
United States
United States
WILLIS, DOUGLAS M
2022-12-1918068237Anti-MARCO Antibodies and Uses ThereofPortsmouth Merger Sub II, LLCPatented Case2025-08-0512378311US20240084000A1
Nadine Jahchan
Michel Streuli
Xi Yang
Linda Liang
Venkataraman Sriram
Joshua Pollack
Kara Mojica
Vladislava Juric
Linnea Haeggblom
Leonard G. Presta
Sayantan Mitra
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
LI, RUIXIANG
2022-10-0718045093ANTI-TREM2 ANTIBODIES AND RELATED METHODSPortsmouth Merger Sub II, LLCPatented Case2025-09-3012428481US20230287110A1
Michel Streuli
Venkataraman Sriram
Aritra Pal
Leonard G. Presta
United States
United States
United States
United States
NATARAJAN, MEERA
2022-08-0217816859TEAD INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2024-03-1211925651US20230148061A1
Alfredo C. CASTRO
United States
HENLEY III, RAYMOND J
2022-05-0617662246INDOLE AHR INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2024-09-0312077542US20230028336A1
Alfredo C. CASTRO
Catherine A. EVANS
United States
United States
CHEN, PO-CHIH
2022-01-0317646787TEAD INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2023-09-1911760728US20220251048A1
Alfredo C. CASTRO
United States
JACKSON, SHAWQUIA
2021-06-1017344839METHODS OF USING ANTI-TREM2 ANTIBODIESPortsmouth Merger Sub II, LLCPatented Case2026-06-3012668629US20210317211A1
Michel Streuli
Leonard G. Presta
Venkataraman Sriram
Aritra Pal
Nadine Jahchan
Mikhail Binnewies
Joshua L. Pollack
Xiaoyan Du
United States
United States
United States
United States
United States
United States
United States
United States
SZPERKA, MICHAEL EDWARD
2020-12-1817126279ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOFIkena Oncology, Inc.Patented Case2023-03-2111608329US20210230153A1
Alfredo C. Castro
Karen J. McGovern
Michael Burke
United States
United States
United States
STOCKTON, LAURA LYNNE
2020-11-2517104237SOLID FORMS OF (R)-N-(2-(5-FLUOROPYRIDIN-3-YL)-8-ISOPROPYLPYRAZOLO[1,5-a][1,3,5]TRIAZIN-4-YL)-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-3-AMINE MALEATE AS ARYL HYDROCARBON RECEPTOR (AHR) INHIBITORSIkena Oncology, Inc.Patented Case2023-02-2811591339US20210253579A1
Alfredo C. CASTRO
James Martin NOLAN III
Sarah Jean BETHUNE
Corinne Marie FOLBERTH
United States
United States
United States
United States
WILLIS, DOUGLAS M
2020-06-0216890196AHR INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2023-01-1711555026US20210017153A1
Alfredo C. CASTRO
Catherine Anne EVANS
United States
United States
CORNET, JEAN P
2020-05-2916887083TEAD INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2022-10-0411458149
ALFREDO C. CASTRO
United States
TRAN, MY CHAU T
2020-05-2916886926TEAD INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2022-03-1511274082US20200407327A1
Alfredo C. CASTRO
United States
JACKSON, SHAWQUIA
2020-04-0816843606INDOLE AHR INHIBITORS AND USES THEREOFIkena Oncology, Inc.Patented Case2022-06-1411358969US20200331917A1
Alfredo C. Castro
Catherine A. Evans
United States
United States
CHEN, PO-CHIH

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B